122 related articles for article (PubMed ID: 17127222)
1. In vitro studies on the release of isoniazid incorporated in poly(epsilon-caprolactone).
Durán N; De Oliveira AF; De Azevedo MM
J Chemother; 2006 Oct; 18(5):473-9. PubMed ID: 17127222
[TBL] [Abstract][Full Text] [Related]
2. Polymeric micelles of poly(2-ethyl-2-oxazoline)-block-poly(epsilon-caprolactone) copolymer as a carrier for paclitaxel.
Cheon Lee S; Kim C; Chan Kwon I; Chung H; Young Jeong S
J Control Release; 2003 May; 89(3):437-46. PubMed ID: 12737846
[TBL] [Abstract][Full Text] [Related]
3. Poly-epsilon-caprolactone microspheres and nanospheres: an overview.
Sinha VR; Bansal K; Kaushik R; Kumria R; Trehan A
Int J Pharm; 2004 Jun; 278(1):1-23. PubMed ID: 15158945
[TBL] [Abstract][Full Text] [Related]
4. Formulation and in vitro characterization of inhalable rifampicin-loaded PLGA microspheres for sustained lung delivery.
Doan TV; Couet W; Olivier JC
Int J Pharm; 2011 Jul; 414(1-2):112-7. PubMed ID: 21596123
[TBL] [Abstract][Full Text] [Related]
5. Stability and in vitro drug release of flurbiprofen-loaded poly-epsilon-caprolactone nanospheres.
Lacoulonche F; Gamisans F; Chauvet A; García ML; Espina M; Egea MA
Drug Dev Ind Pharm; 1999 Sep; 25(9):983-93. PubMed ID: 10518238
[TBL] [Abstract][Full Text] [Related]
6. Size control in production and freeze-drying of poly-ε-caprolactone nanoparticles.
Zelenková T; Fissore D; Marchisio DL; Barresi AA
J Pharm Sci; 2014 Jun; 103(6):1839-50. PubMed ID: 24737658
[TBL] [Abstract][Full Text] [Related]
7. Microspheres made of poly(epsilon-caprolactone)-based amphiphilic copolymers: potential in sustained delivery of proteins.
Quaglia F; Ostacolo L; Nese G; De Rosa G; La Rotonda MI; Palumbo R; Maglio G
Macromol Biosci; 2005 Oct; 5(10):945-54. PubMed ID: 16208680
[TBL] [Abstract][Full Text] [Related]
8. Influence of polymer blends on the characterization of gliclazide--encapsulated into poly (ε-caprolactone) microparticles.
Barakat NS; Shazly GA; Almedany AH
Drug Dev Ind Pharm; 2013 Feb; 39(2):352-62. PubMed ID: 22540378
[TBL] [Abstract][Full Text] [Related]
9. Preparation, characterization and in vitro release properties of ibuprofen-loaded microspheres based on polylactide, poly(epsilon-caprolactone) and their copolymers.
Zhu KJ; Li Y; Jiang HL; Yasuda H; Ichimaru A; Yamamoto K; Lecomte P; Jerome R
J Microencapsul; 2005 Feb; 22(1):25-36. PubMed ID: 16019888
[TBL] [Abstract][Full Text] [Related]
10. Colchicine encapsulation within poly(ethylene glycol)-coated poly(lactic acid)/poly(epsilon-caprolactone) microspheres-controlled release studies.
Das GS; Rao GH; Wilson RF; Chandy T
Drug Deliv; 2000; 7(3):129-38. PubMed ID: 10989913
[TBL] [Abstract][Full Text] [Related]
11. Poly (epsilon-caprolactone)/propolis extract: microencapsulation and antibacterial activity evaluation.
Durán N; Marcato PD; Buffo CM; De Azevedo MM; Esposito E
Pharmazie; 2007 Apr; 62(4):287-90. PubMed ID: 17484285
[TBL] [Abstract][Full Text] [Related]
12. Protein release from poly(epsilon-caprolactone) microspheres prepared by melt encapsulation and solvent evaporation techniques: a comparative study.
Jameela SR; Suma N; Jayakrishnan A
J Biomater Sci Polym Ed; 1997; 8(6):457-66. PubMed ID: 9151193
[TBL] [Abstract][Full Text] [Related]
13. Optimization and performance evaluation of peptide-loaded monolithic poly-epsilon-caprolactone microspheres in mice bearing melanoma B16F1.
Shenoy BD; Venkatesh M; Udupa N
Pharmazie; 2002 Apr; 57(4):256-60. PubMed ID: 11998446
[TBL] [Abstract][Full Text] [Related]
14. In vivo/in vitro pharmacokinetic and pharmacodynamic study of spray-dried poly-(dl-lactic-co-glycolic) acid nanoparticles encapsulating rifampicin and isoniazid.
Booysen LL; Kalombo L; Brooks E; Hansen R; Gilliland J; Gruppo V; Lungenhofer P; Semete-Makokotlela B; Swai HS; Kotze AF; Lenaerts A; du Plessis LH
Int J Pharm; 2013 Feb; 444(1-2):10-7. PubMed ID: 23357255
[TBL] [Abstract][Full Text] [Related]
15. Alginate microspheres of isoniazid for oral sustained drug delivery.
Rastogi R; Sultana Y; Aqil M; Ali A; Kumar S; Chuttani K; Mishra AK
Int J Pharm; 2007 Apr; 334(1-2):71-7. PubMed ID: 17113732
[TBL] [Abstract][Full Text] [Related]
16. Naltrexone-loaded poly[La-(Glc-Leu)] polymeric microspheres for the treatment of alcohol dependence: in vitro characterization and in vivo biocompatibility assessment.
Pagar KP; Vavia PR
Pharm Dev Technol; 2014 Jun; 19(4):385-94. PubMed ID: 23590187
[TBL] [Abstract][Full Text] [Related]
17. Encapsulation of water-soluble drugs by a modified solvent evaporation method. I. Effect of process and formulation variables on drug entrapment.
Alex R; Bodmeier R
J Microencapsul; 1990; 7(3):347-55. PubMed ID: 2384837
[TBL] [Abstract][Full Text] [Related]
18. Design, optimization and evaluation of poly-ε-caprolactone (PCL) based polymeric nanoparticles for oral delivery of lopinavir.
Ravi PR; Vats R; Dalal V; Gadekar N; N A
Drug Dev Ind Pharm; 2015 Jan; 41(1):131-40. PubMed ID: 24180260
[TBL] [Abstract][Full Text] [Related]
19. Degradation and controlled release behavior of epsilon-caprolactone copolymers in biodegradable antifouling coatings.
Faÿ F; Linossier I; Langlois V; Renard E; Vallée-Réhel K
Biomacromolecules; 2006 Mar; 7(3):851-7. PubMed ID: 16529423
[TBL] [Abstract][Full Text] [Related]
20. Lamotrigine loaded poly-ɛ-(d,l-lactide-co-caprolactone) nanoparticles as brain delivery system.
Ammar HO; Ghorab MM; Mahmoud AA; Higazy IM
Eur J Pharm Sci; 2018 Mar; 115():77-87. PubMed ID: 29341900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
